Literature DB >> 6482179

Growth in children with chronic renal failure on conservative treatment.

G Rizzoni, T Basso, M Setari.   

Abstract

Statural growth and its relationship with degree of renal insufficiency were studied in 42 children and 5 infants with chronic renal failure (CRF). Most of the children had a congenital disease or were already ill in the neonatal period. Average GFR was 34 ml/min/1.73 m2 at the beginning and 16 ml at the end of the follow-up period, which averaged 4.3 years (1 to 12 years). Most patients grew at a normal rate; only 3 out of 42 children (7%) and 3 out of 5 infants lost one standard deviation or more during the follow-up period. No correlation was found between the degree of GFR and growth velocity. Catch-up growth was observed only for a 12-month period in 4 children with a bone age of 7 to 8 years. In 10 out of 11 children who reached puberty while under observation, a normal pubertal growth spurt was observed. Suitable and comprehensive controls and treatment can arrest growth retardation in the great majority of children with CRF after the first few years of life, regardless of their GFR. Achievement of a normal growth pattern in infants with CRF during the first year(s) of life remains a major unsolved problem.

Entities:  

Mesh:

Year:  1984        PMID: 6482179     DOI: 10.1038/ki.1984.133

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  24 in total

1.  Treatment of short stature in renal disease with recombinant human growth hormone.

Authors:  L Rees; S P Rigden; G Ward; M A Preece
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

2.  Growth and endocrine function after renal transplantation.

Authors:  L Rees; S A Greene; P Adlard; J Jones; G B Haycock; S P Rigden; M Preece; C Chantler
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

3.  Pubertal growth in children with chronic renal failure on conservative treatment.

Authors:  C Polito; A La Manna; A Iovene; D Stabile
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

4.  Growth in young children with chronic renal failure.

Authors:  A Claris-Appiani; M L Bianchi; P Bini; G Ballabio; M P Caraceni; C Funari; F Terzi; L Romeo; R Rusconi
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

5.  Evaluation of clinical and laboratory parameters during 2 years of growth hormone treatment in prepubertal children with chronic renal failure.

Authors:  D Simon; M Neol; P Brun; D Porquet; P Rocchicioli; C Loirat; P Czernichow
Journal:  Eur J Pediatr       Date:  1996-08       Impact factor: 3.183

6.  Characteristic growth pattern in male X-linked phosphorylase-b kinase deficiency (GSD IX).

Authors:  H M Schippers; G P A Smit; J P Rake; G Visser
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

7.  Growth, development and nutritional status in Japanese children under 2 years on continuous ambulatory peritoneal dialysis.

Authors:  M Honda; Y Kamiyama; K Kawamura; K Kawahara; S Shishido; H Nakai; T Kawamura; H Ito
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

8.  Growth of uremic infants on forced feeding regimens.

Authors:  C L Abitbol; G Zilleruelo; B Montane; J Strauss
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

9.  Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure.

Authors:  H Maxwell; D R Nair; R N Dalton; S P Rigden; L Rees
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

10.  Recombinant human growth hormone in infants and young children with chronic renal insufficiency. Genentech Collaborative Study Group.

Authors:  R N Fine; K M Attie; J Kuntze; D F Brown; E C Kohaut
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.